HungaroTrial is happy to announce their collaboration in the Largest Single Phase III Breast Cancer Clinical Trial in its History.
The trial NATALEE (New Adjuvant TriAl with LEE), a randomized, phase III study will include more than 4,000 patients from around the world.
HungaroTrial was selected to manage sites in the CEE region. Our 19 years’ experience hosting Phase I – IV clinical trials including a wealth of studies in Oncology indications will ensure working with the best trial sites and Key Opinion Leaders of the region.
Our Team is working hard on this project and hopes that these efforts will contribute to new scientific knowledge, making treatment more effective and improving the quality of life of patients globally.